Caprihans India [CAPRIHANS] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Caprihans India Ltd. wins in 8 metrics, Neogen Chemicals Ltd. wins in 11 metrics, with 0 ties. Neogen Chemicals Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Caprihans India Ltd. | Neogen Chemicals Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.43 | 222.22 | Caprihans India Ltd. |
| Price-to-Book Ratio | 0.29 | 5.46 | Caprihans India Ltd. |
| Debt-to-Equity Ratio | 176.33 | 141.47 | Neogen Chemicals Ltd. |
| PEG Ratio | -0.79 | -3.52 | Caprihans India Ltd. |
| EV/EBITDA | 30.04 | 42.55 | Caprihans India Ltd. |
| Profit Margin (TTM) | -7.31% | 2.41% | Neogen Chemicals Ltd. |
| Operating Margin (TTM) | 0.37% | 11.39% | Neogen Chemicals Ltd. |
| EBITDA Margin (TTM) | 0.37% | 11.39% | Neogen Chemicals Ltd. |
| Return on Equity | -14.39% | 4.41% | Neogen Chemicals Ltd. |
| Return on Assets (TTM) | -4.96% | 1.99% | Neogen Chemicals Ltd. |
| Free Cash Flow (TTM) | $815.80M | $-1.22B | Caprihans India Ltd. |
| Dividend Yield | N/A | 0.19% | N/A |
| 1-Year Return | -45.09% | 10.59% | Neogen Chemicals Ltd. |
| Price-to-Sales Ratio (TTM) | 0.17 | 5.56 | Caprihans India Ltd. |
| Enterprise Value | $7.67B | $53.55B | Neogen Chemicals Ltd. |
| EV/Revenue Ratio | 1.09 | 6.55 | Caprihans India Ltd. |
| Gross Profit Margin (TTM) | 33.00% | 47.11% | Neogen Chemicals Ltd. |
| Revenue per Share (TTM) | $485 | $310 | Caprihans India Ltd. |
| Earnings per Share (Diluted) | $-34.07 | $7.47 | Neogen Chemicals Ltd. |
| Beta (Stock Volatility) | 0.47 | 0.22 | Neogen Chemicals Ltd. |
Caprihans India Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Caprihans India Ltd. | -2.31% | 10.68% | 7.30% | 21.01% | -10.87% | -10.92% |
| Neogen Chemicals Ltd. | -0.96% | 6.97% | 12.71% | 39.41% | 74.21% | 61.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Caprihans India Ltd. | -45.09% | -43.54% | -36.12% | -8.35% | 10.82% | 4.56% |
| Neogen Chemicals Ltd. | 10.59% | 19.04% | 106.75% | 609.06% | 609.06% | 609.06% |
Performance & Financial Health Analysis: Caprihans India Ltd. vs Neogen Chemicals Ltd.
| Metric | CAPRIHANS | NEOGEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.23B | ₹44.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,077 | 170,744 |
| 90 Day Avg. Volume | 7,864 | 127,390 |
| Last Close | ₹78.67 | ₹1,882.90 |
| 52 Week Range | ₹50.30 - ₹167.70 | ₹966.70 - ₹1,960.30 |
| % from 52W High | -53.09% | -3.95% |
| All-Time High | ₹266.00 (Sep 11, 2023) | ₹2,420.00 (Dec 09, 2024) |
| % from All-Time High | -70.42% | -22.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.08% | 0.09% |
| Quarterly Earnings Growth | -0.08% | -0.63% |
| Financial Health | ||
| Profit Margin (TTM) | -0.07% | 0.02% |
| Operating Margin (TTM) | 0.00% | 0.11% |
| Return on Equity (TTM) | -0.14% | 0.04% |
| Debt to Equity (MRQ) | 176.33 | 141.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹268.72 | ₹303.78 |
| Cash per Share (MRQ) | ₹26.58 | ₹57.58 |
| Operating Cash Flow (TTM) | ₹598.50M | ₹645.50M |
| Levered Free Cash Flow (TTM) | ₹-621,800,000 | ₹348.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.19% |
| Last 12-Month Dividend | ₹0.00 | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Caprihans India Ltd. vs Neogen Chemicals Ltd.
| Metric | CAPRIHANS (Apr 26, 2026) | NEOGEN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.43 | 222.22 |
| Forward P/E | N/A | 72.26 |
| PEG Ratio | -0.79 | -3.52 |
| Price to Sales (TTM) | 0.17 | 5.56 |
| Price to Book (MRQ) | 0.29 | 5.46 |
| Market Capitalization | ||
| Market Capitalization | ₹1.23B | ₹44.76B |
| Enterprise Value | ₹7.67B | ₹53.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.09 | 6.55 |
| Enterprise to EBITDA | 30.04 | 42.55 |
| Risk & Other Metrics | ||
| Beta | 0.47 | 0.22 |
| Book Value per Share (MRQ) | ₹268.72 | ₹303.78 |
Financial Statements Comparison: Caprihans India Ltd. vs Neogen Chemicals Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CAPRIHANS (2025) | NEOGEN (2025) |
|---|---|---|
| Revenue/Sales | 7.38B | 7.58B |
| Cost of Goods Sold | 5.37B | 4.44B |
| COGS % of Revenue | 72.7% | 58.6% |
| Gross Profit | 2.01B | 3.13B |
| Gross Margin | 27.3% | 41.4% |
| Research & Development | N/A | 11.50M |
| Operating Income (EBIT) | -70.90M | 1.09B |
| Operating Margin | -1.0% | 14.4% |
| EBITDA | 504.30M | 1.31B |
| EBITDA Margin | 6.8% | 17.3% |
| Pre-Tax Income | -786.90M | 501.60M |
| Pre-Tax Income % of Revenue | -10.7% | 6.6% |
| Income Tax | -165.10M | 153.30M |
| Income Tax % of Revenue | -2.2% | 2.0% |
| Net Income (Profit) | -621.80M | 348.30M |
| Profit Margin | -8.4% | 4.6% |
Balance Sheet & Liquidity Metrics
| Metric | CAPRIHANS (2025) | NEOGEN (2025) |
|---|---|---|
| Cash & Equivalents | 56.10M | 49.60M |
| Total Current Assets | 2.56B | 10.00B |
| Total Current Assets % of Revenue | 34.7% | 132.0% |
| Total Current Liabilities | 3.26B | 7.33B |
| Total Current Liabilities % of Revenue | 44.1% | 96.8% |
| Long-Term Debt | 4.53B | 1.94B |
| Long-Term Debt % of Revenue | 61.3% | 25.6% |
| Total Shareholders Equity | 4.32B | 7.89B |
| Retained Earnings | 229.10M | 2.28B |
| Retained Earnings % of Revenue | 3.1% | 30.1% |
| Property, Plant & Equipment | 8.76B | 890.30M |
Cash Flow Statement Comparison
| Metric | CAPRIHANS (2025) | NEOGEN (2025) |
|---|---|---|
| Operating Cash Flow | 598.50M | 645.50M |
| Operating Cash Flow % of Revenue | 8.1% | 8.5% |
| Capital Expenditures | 664.30M | -3.17B |
| Free Cash Flow | 815.80M | -1.22B |
| FCF Margin | 11.1% | -16.1% |
| Debt Repayment | -858.80M | -718.00M |
| Common Stock Repurchase | -463.50M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CAPRIHANS | NEOGEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 15.91M | 27.38M |
| Float Shares | 2.99M | 13.28M |
| % Held by Insiders | 77.57% | 53.98% |
| % Held by Institutions | 0.00% | 23.81% |
| % Held by Public | 22.43% | 22.21% |
Dividend Analysis & Yield Comparison: Caprihans India Ltd. vs Neogen Chemicals Ltd.
| Metric | CAPRIHANS | NEOGEN |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹3.00 |
| Last 12-Month Dividend Yield | N/A | 0.19% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹2.00 |
| 3-Year Avg Dividend Yield | N/A | 0.11% |
| 3-Year Total Dividends | ₹0.00 | ₹6.00 |
| Ex-Dividend Date | N/A | Sep 19, 2025 |